FluoGuide A/S

STO-FLUO
Nasdaq Stockholm
Healthcare Biotechnology
Global Rank
#28092
Country Rank
#87
Market Cap
64.64 M
Price
4.75
Change (%)
2.27%
Volume
21,624

FluoGuide A/S's latest marketcap:

64.64 M

As of 07/26/2025, FluoGuide A/S's market capitalization has reached $64.64 M. According to our data, FluoGuide A/S is the 28092th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 64.64 M
Revenue (ttm) 60,449.41
Net Income (ttm) -4,636,086.49
Shares Out 13.62 M
EPS (ttm) -0.35
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/28/2025
Market Cap Chart
Data Updated: 07/26/2025

FluoGuide A/S's yearly market capitalization.

FluoGuide A/S has seen its market value grow from kr39.73 M to kr614.27 M since 2019, representing a total increase of 1,445.97% and an annual compound growth rate (CAGR) of 63.44%.
Date Market Cap(kr) Market Cap(USD) Change (%) Global Rank
07/26/2025 kr614.27 M $64.64 M 12.64% 28092
12/30/2024 kr533.23 M $47.94 M -28.57% 28286
12/29/2023 kr746.52 M $73.61 M 68.5% 25143
12/30/2022 kr443.04 M $42.27 M -54.38% 28015
12/30/2021 kr971.21 M $106.83 M 4.81% 22697
12/30/2020 kr926.64 M $112.12 M 2232.14% 19960
12/30/2019 kr39.73 M $4.22 M 31058

Company Profile

About FluoGuide A/S

FluoGuide A/S is a clinical-stage biotechnology company based in Denmark, specializing in innovative solutions to improve surgical outcomes by making cancerous tissues fluorescent. Founded in 2018 and headquartered in Copenhagen, the company is dedicated to advancing cancer treatment through precision-guided surgery.

Key Product Candidate

The company's lead product, FG001, is currently in clinical development with the following applications:

  • Phase IIa & IIb trials for high-grade glioma treatment.
  • Phase II clinical trials for lung cancer and head & neck cancer.

Mission & Focus

FluoGuide A/S aims to enhance surgical precision by enabling real-time visualization of cancer cells, improving resection accuracy and patient outcomes. Their technology supports oncologists in identifying and removing malignant tissues more effectively.

Frequently Asked Questions

  • What is FluoGuide A/S's (STO-FLUO) current market cap?
    As of 07/26/2025, FluoGuide A/S (including the parent company, if applicable) has an estimated market capitalization of $64.64 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • FluoGuide A/S global market capitalization ranking is approximately 28092 as of 07/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.